Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 4701-4750 of 6046 result(s).
CYDY CytoDyn Inc
10/20/2020 10:24:39 AM
He's been tweeting less lately. I t (1)
CYDY CytoDyn Inc
10/20/2020 10:23:40 AM
Does an eua approval mean that anyo (4)
CYDY CytoDyn Inc
10/20/2020 10:18:45 AM
The DSMC isn't going to advise a se (11)
CYDY CytoDyn Inc
10/20/2020 10:09:57 AM
They need to incentivize hospitals (12)
CYDY CytoDyn Inc
10/20/2020 8:58:54 AM
Neither the DSMC or FDA are going t
CYDY CytoDyn Inc
10/20/2020 8:57:13 AM
A reply at ihub to Grip It and Sip (6)
CYDY CytoDyn Inc
10/20/2020 8:41:09 AM
If data was forwarded it would be a
CYDY CytoDyn Inc
10/20/2020 8:37:43 AM
With 23% bioavailability for Maravi (2)
CYDY CytoDyn Inc
10/20/2020 8:02:21 AM
That Cytodyn is "seeking ongoing gu (3)
CYDY CytoDyn Inc
10/20/2020 7:47:44 AM
That EUA is based on risk/benefit a (5)
CYDY CytoDyn Inc
10/20/2020 7:39:22 AM
DSMC also requests another data rev (3)
CYDY CytoDyn Inc
10/20/2020 7:33:29 AM
We should have at least 5 additiona (1)
CYDY CytoDyn Inc
10/20/2020 7:23:08 AM
It's obviously 42 days after the 29 (8)
CYDY CytoDyn Inc
10/20/2020 7:12:32 AM
The extension to 42 days should cov (7)
CYDY CytoDyn Inc
10/20/2020 6:59:54 AM
If halt is .005 - using a double bi (4)
CYDY CytoDyn Inc
10/20/2020 4:42:25 AM
Dr. Patterson on Trial Site News Po (3)
CYDY CytoDyn Inc
10/20/2020 4:19:49 AM
With long haulers being inflammator (1)
CYDY CytoDyn Inc
10/19/2020 2:45:38 PM
To apply for an EIND the disease mu (1)
CYDY CytoDyn Inc
10/19/2020 1:37:20 PM
Heard him on NPR this morning telli (5)
CYDY CytoDyn Inc
10/19/2020 1:34:34 PM
I go back and forth through things (2)
CYDY CytoDyn Inc
10/19/2020 1:27:20 PM
Lyme disease is on the master disea (9)
CYDY CytoDyn Inc
10/19/2020 10:27:09 AM
No no no. If Dr. P is selling his k (2)
CYDY CytoDyn Inc
10/19/2020 10:21:33 AM
NP falsely claimed that the CCR5 oc (4)
CYDY CytoDyn Inc
10/19/2020 4:36:22 AM
Henoch-Schönlein purpura is a type (1)
CYDY CytoDyn Inc
10/19/2020 2:01:38 AM
If you just halt upon receipt of th (2)
CYDY CytoDyn Inc
10/19/2020 1:56:18 AM
I wondered whether the 5 times the (6)
CYDY CytoDyn Inc
10/19/2020 1:03:08 AM
I'm 100% for unblinding too. Anyone (8)
CYDY CytoDyn Inc
10/19/2020 12:53:30 AM
The PR does not inspire confidence. (7)
CYDY CytoDyn Inc
10/19/2020 12:34:02 AM
With a continue recommendation data (1)
CYDY CytoDyn Inc
10/19/2020 12:31:23 AM
The one thing needed is either enou (1)
CYDY CytoDyn Inc
10/18/2020 11:37:21 PM
I lose this in the sun, have no clu (1)
CYDY CytoDyn Inc
10/18/2020 11:23:03 PM
With the MHRA's ability to get pati
CYDY CytoDyn Inc
10/18/2020 11:20:01 PM
Also, does anyone else find it pecu (1)
CYDY CytoDyn Inc
10/18/2020 11:09:04 PM
Cytodyn should have been granting r (3)
CYDY CytoDyn Inc
10/18/2020 10:19:57 PM
My question - Is the virus still de (6)
CYDY CytoDyn Inc
10/17/2020 4:26:39 PM
Guerilla tactics - 50 Antifa protes (10)
CYDY CytoDyn Inc
10/17/2020 3:57:33 PM
Scroll down to the bottom, click on
CYDY CytoDyn Inc
10/17/2020 3:53:20 PM
The secondary endpoints that would (1)
CYDY CytoDyn Inc
10/17/2020 3:34:51 PM
Maraviroc downregulates MCP-1. I ha (9)
CYDY CytoDyn Inc
10/17/2020 1:10:10 PM
So you work for the FDA? The FDA po (3)
CYDY CytoDyn Inc
10/17/2020 1:01:44 PM
CTAP is for initiating drug trials. (2)
CYDY CytoDyn Inc
10/17/2020 11:55:41 AM
I took a quick look at one of cenic (5)
CYDY CytoDyn Inc
10/17/2020 9:26:41 AM
At least if we knew it was greater (4)
CYDY CytoDyn Inc
10/17/2020 9:23:18 AM
Cytodyn (or actually Amarex as the (3)
CYDY CytoDyn Inc
10/17/2020 7:40:38 AM
Predetermined p value for trial hal (6)
CYDY CytoDyn Inc
10/17/2020 5:40:55 AM
The p value shows the likelihood of (4)
CYDY CytoDyn Inc
10/17/2020 4:05:36 AM
Here's a question - The head of the (6)
CYDY CytoDyn Inc
10/17/2020 3:34:59 AM
An EUA submittal is not subject to (2)
CYDY CytoDyn Inc
10/17/2020 3:32:36 AM
But wouldn’t that mean we are equ (1)
CYDY CytoDyn Inc
10/17/2020 3:29:09 AM
Since leronlimab is a biological it (8)
Go to page:
  • << First
  • < Previous
  • 94
  • 95
  • Next >

Recent Articles

  • Understanding Riksbank's Recent Government Bond Auctions
  • Butterfly Network's Post-Market Surge: Understanding the 15% Jump
  • Anticipating Earnings: Worthington Enterprises Strategies for Q1
  • Revolutionizing Women's Health: Truelli Set to Innovate Care
  • Toobit Launches Innovative Presale Event for MechaConquest
  • Unlocking Financial Savings with RadCred's AI Loan Matching
  • Apple's iPhone 17 Success in Asian Markets: Insights and Trends
  • XCMG Highlights Sustainability With Revolutionary Hybrid Crane
  • Bayport Intermediate Holdco PLC Updates Noteholders on Results
  • Bayport Management Ltd Reveals Results of Noteholders Procedure
  • Global Orthodontic Experts Explore Innovations at Smartee HQ
  • A New Era in Mental Health: Launch of States of Mind Platform
  • OpenOcean's V4 Drift: Transforming DeFi with Smarter Routing
  • Embracing Digital Innovation for Cultural Preservation Worldwide
  • Navigating Loan Options After Fed's Interest Rate Cuts
  • Diversified Energy Company Announces Significant Share Buyback
  • Advantest Showcases Innovative Solutions at Conference Event
  • Advantest Showcases Innovative Test Solutions at ITC 2025
  • PepsiCo Faces Challenges Amid Rising Debt and Cash Flow Issues
  • Eastroc Beverage Climbs the Ranks in 2025 Brand Valuation List
  • Coway's Icon Pro Water Purifier Receives Prestigious Design Award
  • EQT AB Appoints Nomination Committee for 2026 Meeting
  • Exploring Innovative Senior Care Solutions with CT Community Care
  • Exploring the Rise of Mobile Communication Antennas Amid 5G Growth
  • NB Private Equity Partners’ Recent Share Buyback Validates Strategy
  • BCP S.A. Announces Call on EUR500 Million Senior Notes
  • FedEx Faces $1 Billion Challenge Amid Changing Trade Policies
  • Factor2 Energy Secures $9.1M for Scalable Geothermal Solutions
  • Ignitis Group Maintains Strong BBB+ Credit Rating Status
  • Anteris Technologies Reschedules Stockholder Meeting for Future Votes
  • Ignitis Group Maintains Strong BBB+ Credit Rating Stability
  • Anteris Technologies Global Corp. Updates Shareholder Meeting Plans
  • QuantumScape Stock Shines with Significant After-Hours Gains
  • Recent Surge in UPS Stock Following Acquisition Decision
  • Global Orthodontic Experts Unite at Smartee's Headquarters
  • BlueNord ASA Announces New Structure for Executive Shares
  • Bekaert's Share Buyback Program: Key Updates and Impacts
  • Tryngolza® Approval Marks New Hope for FCS Patients
  • Insightful Overview of Foresight Group's Share Buyback Activity
  • Bekaert Announces Enhanced Public Transparency Measures
  • Artea Bank Partners with Žalgiris: A New Era in Sports Innovation
  • KDP's Strategic Move: Insights into JDE Peet's Potential Acquisition
  • Pulsar Helium Announces Strong Helium Production Potential
  • Wolters Kluwer Finalizes Share Capital Reduction for Growth
  • Keurig Dr Pepper's Strategic Move for JDE Peet’s Acquisition
  • The9 Limited Engages in Major JV for Mobile Game Expansion
  • Middlefield Canadian Income PCC Reports Strong Half-Year Growth
  • Irish Continental Group Strengthens Position with Share Buyback
  • Pulsar Helium Boosts Helium Reserves at Jetstream Wells
  • Keurig Dr Pepper's Strategic Acquisition Plans for JDE Peet's
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site